Suppr超能文献

小鼠胚胎卵黄囊中的造血干细胞。

Hematopoietic stem cells in the mouse embryonic yolk sac.

作者信息

Auerbach R, Huang H, Lu L

机构信息

Laboratory of Developmental Biology, University of Wisconsin, Madison 53706, USA.

出版信息

Stem Cells. 1996 May;14(3):269-80. doi: 10.1002/stem.140269.

Abstract

The yolk sac is the first site of hematopoiesis during mammalian development. The yolk sac is also the first site of blood vessel development. Development of the blood islands in the yolk sac is an integrated process in which these two developmental events, hematopoiesis and vasculogenesis, proceed in concert. This review focuses on mouse yolk sac hematopoietic stem cells (YS-HSC), describing their differentiation in vitro and in vivo. YS-HSC go through a progressive series of changes prior to the initiation of lineage-specific differentiation. Experiments tracing their origins from postulated hemangioblasts, and the subsequent interaction between these stem cells and yolk sac endothelial cells are described. Differences between the extraembryonic YS-HSC and HSC found later within the embryo, perinatally or in adults, are described. YS-HSC have greater reproductive capability than HSC obtained from fetal liver, umbilical cord blood or adult bone marrow; they do not yet express major histocompatibility complex-associated antigens and they are able to reconstitute adult immunocompromised animals even when introduced in small numbers (< 100 cells/mouse). With recent results demonstrating the feasibility of expanding YS-HSC in vitro as well as of introducing new genes into these cells by transfection, the YS-HSC shows promise both as a means of achieving long-term restitution of hematopoiesis across histocompatibility barriers and as a self-renewing vehicle for gene transfer.

摘要

卵黄囊是哺乳动物发育过程中造血的第一个部位。卵黄囊也是血管发育的第一个部位。卵黄囊中血岛的发育是一个整合过程,其中造血和血管生成这两个发育事件协同进行。本综述聚焦于小鼠卵黄囊造血干细胞(YS-HSC),描述其在体外和体内的分化情况。YS-HSC在开始谱系特异性分化之前会经历一系列渐进的变化。文中描述了追踪其源自假定的成血管细胞的实验,以及这些干细胞与卵黄囊内皮细胞之间随后的相互作用。还描述了胚外YS-HSC与后来在胚胎期、围产期或成体中发现的造血干细胞之间的差异。YS-HSC比从胎儿肝脏、脐带血或成人骨髓中获得的造血干细胞具有更强的增殖能力;它们尚未表达主要组织相容性复合体相关抗原,并且即使少量引入(<100个细胞/小鼠)也能够重建成年免疫受损动物的造血功能。随着最近的结果证明在体外扩增YS-HSC以及通过转染将新基因导入这些细胞的可行性,YS-HSC作为跨越组织相容性屏障实现造血长期恢复的手段以及作为基因转移的自我更新载体都显示出前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验